Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin LymphomaLauri M. Burroughs, David G. Maloney, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 264
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A. Kharfan‐Dabaja, Marcie Riches, Merav Bar et al.|Transplantation and Cellular Therapy|2021Cited by 180
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experienceBeatriz Morillo-Gutiérrez, Mary Slatter, Rita Beier et al.|Blood|2016Cited by 134
Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) SurveyAlice Chan, M. Teresa de la Morena, Jennifer W. Leiding et al.|Frontiers in Immunology|2020Cited by 81
Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid MalignanciesEmily Merkel, Ann Dahlberg, Ted Gooley et al.|Transplantation and Cellular Therapy|2025Cited by 0